The Biochips
Market Outlook and Analysis by Type, by Technology, By End
User-Forecast Till 2030
As per the latest report furnished by
Market Research Future (MRFR), the global Biochips Market held the value of USD 7,300
million in 2017, with the growth rate of the market predicted at 11.6% over the
forecast period (2022-2030).
The biochips market refers to the global
industry that produces and sells small electronic devices designed for use in
medical and biological research. These devices, also known as microarrays,
allow scientists to analyze and measure the presence and activity of biological
molecules, such as DNA, RNA, and proteins, within a sample.
The global biochips market is expected to
experience significant growth in the coming years, driven by factors such as
the increasing demand for personalized medicine, rising prevalence of chronic
diseases, and the growing use of biochips in drug discovery and development.
Growth Drivers and
Challenges
Microfluidics and Microarray technology have revolutionized
the field of scientific research by reducing costs as well as time required for
conventional laboratory-based approach of research. Microfluidics provide
various benefits like reduced assay costs owing to need for less amount of
sample in nano-liter or pico liter volume, increased sensitivity, accuracy, and
throughput as compared to traditional laboratory procedures and also reduced
labor cost. The products that are based on DNA microarrays, lab-on-a-chip,
protein chips, as well as organ-on-a-chip technologies have managed to
alleviate the existing problems associated with time and costs in their
respective fields. Also, the research and development activities are underway
at present, regarding the microarray and microfluidic technologies for numerous
applications. This factor will turn out to be a high point for the market
growth in the coming years. For instance, in the year 2017, Griffith Institute
for Drug Discovery (GRIDD) started the process of developing microfluidic
platform to further decrease time and costs needed for research.
To sum it up, extensive research and
development in the field is expected to eventually elevate the adoption rate of
these technologies. Case in point is the successful demonstration by scientists
at Harvard University, which used the paper and threads as an ideal option for
cheap microfluidic devices. moreover, integrating electrodes and electrical
textile valves into such devices will make it even more useful.
Going forward, the Laboratory of Integrated
Bio Medical/Nanotechnology & Applications at the University of Illinois
went on to develop a microfluidic POC sepsis chip that has the ability to
quantify the total white blood cell counts and CD64 expression levels on
neutrophils in just 30 minutes. This was done by using just 10 microliters of a
blood sample. As per the National Center for Biotechnology Information (NCBI),
a microfluidic biochip is capable of isolating single circulating tumor cells,
delivering personalized medicine in non-small cell lung cancer patients. The
sum of all these factors, including various research and development activities
along with the benefits offered by this technology, will prove to be highly
beneficial for the Biochips Market share growth in the near future.
Market
Segmentation
The global biochips market share is segmented based on type,
technology, and end user.
Type-based segments in the global market
include DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue
arrays. DNA chips is sub-segmented into gene expression, SNP genotyping, cancer
diagnosis & treatment, genomics, drug discovery, agricultural
biotechnology, and others. Furthermore, lab-on-a-chip is further divided into
clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of
care), Proteomics, Drug Discovery, and others. In addition, protein chips
consist of proteomics, expression profiling, diagnostics, high-throughput
screening, drug discovery, others.
On the basis of technology, the market is
segmented into microarrays and microfluidics.
The end users in the biochips market are
biotechnology and pharmaceutical companies, hospitals and diagnostics centers,
academic & research institutes, and others.
Key Players
GE Healthcare, Bio-Rad Laboratories Inc.,
Cepheid Inc., Agilent Technologies, Inc., Perkinelmer Inc., Fluidigm
Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc, Roche Diagnostics,
Abbott Laboratories, are some of the established companies competing in the
global Biochips Market share.
Regional Analysis
Regionally, the global biochips market is
split into the key regions of Europe, Asia Pacific, the Americas, along with
the Middle East & Africa.
The biochips market, in the Americas, is
flourishing in the regions of North America and South America, wherein the
North America market is further split into the United States (US) and
Canada. The humongous share belonging to
the region can be credited to the expanding geriatric population; growing
prevalence of lifestyle diseases like asthma, diabetes, and cardiac disorders;
increasing adoption of biochips; and a substantial number of ongoing research
activities and discoveries taking place related to biochips.
The Europe Biochips Market share is divided
into Western Europe and Eastern Europe. The Western Europe biochips market is
spread across the countries of France, Germany, the United Kingdom (UK), Spain,
Italy, and the rest of Western Europe.
The biochips market in Asia Pacific is
thriving in the countries like India, China, Japan, Australia, South Korea, and
the rest of Asia Pacific. Easy access to modern and latest technologies along
with growing government initiatives and cost advantage of the technology is set
to benefit the regional market to a large extent.
Lastly, the biochips market in the Middle
East & Africa has is spread across the main regions of Middle East and
Africa.
Recent News
January 2019 – Swiss scientists have made
use of a lab-on-a-chip device for the
diagnosis of the neurodegenerative condition i.e. Huntington’s disease, derived
from DNA in the blood in just five minutes. This will help predict if the
patient has Huntington’s as one region of the gene is mutated, including
various repeated code which will make it longer in length compared to the
healthy gene.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments